Gretchen Cuda Kroen

Articles

AHA Awards Nonprofit Grants to Address Food and Healthcare Shortages Due to COVID-19

June 17, 2020

Twenty two nonprofit organizations have been awarded COVID-19 Rapid Response Grants as part of the American Heart Association’s Voices for Healthy Kids initiative.The grants range from $20,000 to $50,000 and will support work focused on improving access to healthy food, increasing access to health care and addressing income needs during and beyond the pandemic.

Diabetes Trial Shows Prevention Benefits Two Decades Later

June 16, 2020

New data released today from the Diabetes Prevention Program Outcomes Study (DPPOS) shows that in over 2000 patients followed for an average of 22 years, lifestyle programs and treatment with metformin continues to prevent the development of type 2 diabetes (T2D) in at risk populations.

Type 1 Diabetes Triggered First Two Years of Life, Research Says

June 15, 2020

New data from the Environmental Determinants of Diabetes in the Young (TEDDY) study illuminate the environmental triggers that are thought to cause the autoimmune response leading to type 1 diabetes(T1D) and celiac disease. The research, presented in a symposium at the American Diabetes Association meeting.shows that the destruction of the beta cells begins in the first two years of life.

Late Night Meals Bad for Blood Sugar Control and Weight Loss

June 12, 2020

A study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism has found that eating a late may be a contributing factor to weight gain and hyperglycemia -- factors that may also exaccerbate heart disease.

Women, Minorities and Older Adults Still Underrepresented in Clinical Trials: Conversation with Erin Michos MD

June 11, 2020

The outcomes of clinical trials are often affected by the diversity of the patient population studied.  Things like race and gender can make a real difference in the way drugs work– and yet women, minorities and older adults continue to be underrepresented in pivotal trials for new medications .  Two recent studies demonstrate that fact over the last several decades.  And although the proportion of these populations enrolled in clinical trials has increased, it is still well out of step with the number of patients affected by the diseases in question. Sr. Editor Gretchen Cuda Kroen spoke with Dr. Erin Michos,  co-author on those studies about the origins of the disparity, and what what we can do about it.

Glucose Management of COVID-19 Patients in the ICU Gets New Provider Guidelines

June 10, 2020

According to the report, more than 20 percent of COVID patients in the ICU are patients with diabetes, presenting challenges for the clinicians managing their care.  Diabetic patients with COVID-19 in the ICU need both complex medical management of their COVID disease, along with blood sugar control to minimize complications and mortality risk- and that can require multiple patient interactions that put the provider at risk.